Absci Corporation (ABSI) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Vancouver, WA, 미국. 현재 CEO는 Sean McClain.
ABSI 을(를) 보유 IPO 날짜 2021-07-22, 156 명의 정규직 직원, 에 상장 NASDAQ Global Select, 시가총액 $485.08M.
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
